Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D-Afg]: Feasibility Trial in Rural Kabul-Afghanistan

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: t
View:

• For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above.

• Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent.

• All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate.

• Participants who can attend the scheduled meetings and interventions as per the study protocol.

Locations
Other Locations
Afghanistan
HealthNet TPO, Afghanistan
RECRUITING
Kabul
Contact Information
Primary
Abdul Rahman Shahab, MPH
abdul.shahab@hntpo.org
+93786611325
Backup
Sayed Murtaza Sadat Hofiani, MPH
rsch.coord@hntpo.org
+93700555600
Time Frame
Start Date: 2024-12-24
Estimated Completion Date: 2027-09-30
Participants
Target number of participants: 250
Treatments
Experimental: PLA Intervention group
Participatory Learning and Action (PLA) sessions adapted from the D-MAGIC trial (Bangladesh). The PLA intervention will be delivered to community members with type II diabetes to improve diabetes-related outcomes. Sessions will be group-based, lasting approximately 2-3 hours each. Participants in this arm will be followed and evaluated 10 months after the start of the intervention using a structured, validated, literature-based endline assessment checklist to assess feasibility and outcomes.
No_intervention: Usual care (control) group
Participants in the control arm will receive standard practice (usual care) and comprehensive information about the project but will not receive the PLA intervention.
Related Therapeutic Areas
Sponsors
Leads: HealthNet Transcultural Psychosocial Organization
Collaborators: University of York, Aga Khan University, Khyber Medical University Peshawar, National Institute for Health Research, United Kingdom

This content was sourced from clinicaltrials.gov